By increasing Treg numbers, IL-10 further reduces the effectiveness of cytotoxic T-cells (CD8 + T-cells) and helper T-cells (CD4 + T-cells), weakening the immune response against breast cancer cells. This evidence concerns the gene IL10 and breast carcinoma.